Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sherlock

Showing results (251-260 of 454) with videos related to

Pageof 46
Sort By:
Gut|May 1, 1973
Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver diseaseF J Dudley, M J O'Shea, A Ajdukiewicz, et al.
Gastroenterology|June 1, 1976
Piperazine hepatitisA N Hamlyn, J S Morris, I Sarkany, et al.
Gut|May 1, 1976
Proceedings: C3 metabolism in HBsAg positive and negative chronic active liver disease (CALD)E Elias, B J Potter, H C Thomas, et al.
Gut|February 1, 1971
Copper kinetics in liver diseaseR A Smallwood, B McIlveen, V M Rosenoer, et al.
Liver|September 1, 1982
Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's diseaseR S Graul, O Epstein, S Sherlock, et al.
Gut|October 1, 1972
Renal and intrarenal blood flow in non-cirrhotic portal hypertensionM C Kew, C Limbrick, R R Varma, et al.
Gut|January 1, 1983
Copper chelation therapy in intrahepatic cholestasis of childhoodJ Evans, H Zerpa, L Nuttall, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1980
An epidemic of type B viral hepatitis: its course and outcomeA P Kirk, A Vitale, M Y Morgan, et al.
Diabetologia|August 1, 1980
Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damageG Smith-Laing, H Orskov, M B Gore, et al.
Gut|May 1, 1976
Proceedings: Lymphocyte mediated cytotoxicity for Chang liver cells in acute and chronic liver diseaseE Jacques, D De Villers, H C Thomas, et al.
Pageof 46

Showing results (251-260 of 454) with videos related to

Sort By:
Pageof 46
Gut|May 1, 1973
Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver diseaseF J Dudley, M J O'Shea, A Ajdukiewicz, et al.
Gastroenterology|June 1, 1976
Piperazine hepatitisA N Hamlyn, J S Morris, I Sarkany, et al.
Gut|May 1, 1976
Proceedings: C3 metabolism in HBsAg positive and negative chronic active liver disease (CALD)E Elias, B J Potter, H C Thomas, et al.
Gut|February 1, 1971
Copper kinetics in liver diseaseR A Smallwood, B McIlveen, V M Rosenoer, et al.
Liver|September 1, 1982
Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's diseaseR S Graul, O Epstein, S Sherlock, et al.
Gut|October 1, 1972
Renal and intrarenal blood flow in non-cirrhotic portal hypertensionM C Kew, C Limbrick, R R Varma, et al.
Gut|January 1, 1983
Copper chelation therapy in intrahepatic cholestasis of childhoodJ Evans, H Zerpa, L Nuttall, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1980
An epidemic of type B viral hepatitis: its course and outcomeA P Kirk, A Vitale, M Y Morgan, et al.
Diabetologia|August 1, 1980
Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damageG Smith-Laing, H Orskov, M B Gore, et al.
Gut|May 1, 1976
Proceedings: Lymphocyte mediated cytotoxicity for Chang liver cells in acute and chronic liver diseaseE Jacques, D De Villers, H C Thomas, et al.
Pageof 46